Develops large-scale neutral-atom quantum computers for fault-tolerant commercial and government applications
D
DCVC
Activity from announced rounds
Activity in this selectionEnterprise software
DCVC is an investment firm identified by TypeSafe AI as an existing investor and by its own communications as a backer of Shennon Biotechnologies.
Recorded funding activity
TypeSafe turns unstructured inputs into typed decisions and probability scores for automated software. Shennon develops T-cell engager therapies for solid tumors. Separate TypeSafe financings remain separate events under one investor history.
Sources
- Rounds participated in
- 5
- Confirmed lead rounds
- — 5 roles undisclosed
- New companies
- 5 First participation on record · 0 follow-on
- Funding in participating rounds
- $562M 5 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
5 in this selectionAtom Computing
$100MSeries C
Role not disclosedQuantum Motion
Builds utility-scale quantum computers using industry-standard silicon transistors
$160MSeries C
Role not disclosedKanvas Biosciences
Develops microbiome-based live biotherapeutics for cancer patients who do not respond to immunotherapy
$48MSeries A
Role not disclosedHalter
Develops GPS-enabled cattle collars using sensors, software and AI.
$220MSeries E
Role not disclosedChariot Defense
Chariot Defense develops power-distribution systems for military use.
$34MSeries A
Role not disclosed